Detalhe da pesquisa
1.
Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia.
Haematologica
; 100(4): 511-6, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25596264